Avalide
Product Images NDC 54868-4494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Avalide (NDC 54868-4494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Figure 1a (Figure 1a)

Image Of Figure 1a (Figure 1a)
A line graph comparing the percentage of patients with systolic blood pressure less than 140 mmHg against baseline systolic blood pressure in mmHg across different studies, labeled as Avl. Study V, Irb. Study V, HCTZ Study V, Avl. Study VI, and Irb. Study VI.*
FDA Label Image

Image Of Figure 1b (Figure 1b)

Image Of Figure 1b (Figure 1b)
A line graph depicting the percentage of subjects with systolic blood pressure (SBP) less than 130 mmHg in relation to baseline SBP values. The graph compares different studies labeled as Av. and Iv. Study V and VI.*
FDA Label Image

Image Of Figure 2a (Figure 2a)

Image Of Figure 2a (Figure 2a)
A line graph showing the percentage of diastolic blood pressure (DBP) below 90 mmHg over a range of baseline DBP values from 90 to 130 mmHg. The graph includes multiple study lines labeled as Av. Study V, Irb. Study V, HCTZ Study V, Av. Study VI, and Irb. Study VI, depicting comparative results of blood pressure reductions.*
FDA Label Image

Image Of Figure 2b (Figure 2b)

Image Of Figure 2b (Figure 2b)
A line graph showing the percentage of diastolic blood pressure (DBP) less than 80 mmHg plotted against baseline DBP (mmHg). Multiple studies are represented with different colored and styled lines, comparing the effectiveness of Avalide (indicated by solid and dashed lines) with hydrochlorothiazide (HCTZ) and other study groups.*
FDA Label Image

Image Of Figure 3 (Figure 3)

Image Of Figure 3 (Figure 3)
A scatter plot with a curve showing the relationship between Irbesartan Dose (mg/day) on the x-axis and reduction in trough SeSBP (mmHg) on the y-axis. The figure illustrates the placebo-subtracted blood pressure reduction response to varying doses of Irbesartan.*
FDA Label Image

Image Of Figure 4 (Figure 4)

Image Of Figure 4 (Figure 4)
A scatter plot with a curve fitting showing the relationship between irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeDBP (mmHg) on the y-axis. The graph depicts increasing blood pressure reduction with higher doses of irbesartan, leveling off at higher doses.*
FDA Label Image

Image Of Hydrochlorothiazide Chemical Structure (Hydrochlorothiazide Chemical Structure)

Image Of Hydrochlorothiazide Chemical Structure (Hydrochlorothiazide Chemical Structure)
Chemical structure of Avalide active ingredient depicted in a molecular diagram showing atoms and bonds, including sulfonamide and chlorine substituents on a benzene ring.*
FDA Label Image

Image Of Irbesartan Chemical Structure (Irbesartan Chemical Structure)

Image Of Irbesartan Chemical Structure (Irbesartan Chemical Structure)
Chemical structure of the active ingredient related to Avalide, showing multiple ring systems including a cyclopentane-based lactam, a phenyl group linked by a propyl chain, and a triazole-containing fused heterocyclic system.*
FDA Label Image

Image Of 150/12.5 mg Package Label (Package Label 01)

Image Of 150/12.5 mg Package Label (Package Label 01)
Label for Avalide 150/12.5 distributed by Physicians Total Care, Inc., Tulsa, OK. The label shows lot number 0000, expiration date 01/60, and includes a barcode. The product is manufactured by Bristol-Myers Squibb/Sanofi, New York, NY.*
FDA Label Image

Image Of 300/12.5 mg Package Label (Package Label 02)

Image Of 300/12.5 mg Package Label (Package Label 02)
Packaging label for Avalide 300/12.5 mg. The label includes the lot number, expiration date, and a barcode. It indicates Physicians Total Care, Inc. as the distributor and lists Bristol-Myers Squibb/Sanofi as the manufacturer.*
FDA Label Image

Image Of 300/25 mg Package Label (Package Label 03)

Image Of 300/25 mg Package Label (Package Label 03)
Packaging label for Avalide 300/25MG distributed by Physicians Total Care Inc., Tulsa, OK. The label includes lot number 0000 and expiration date 01/60, with manufacturer Bristol-Myers Squibb/Sanofi in New York, NY. A barcode and NDC 54068-5465-0 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.